Exelixis (EXEL)
(Delayed Data from NSDQ)
$39.14 USD
+0.13 (0.33%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $39.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Exelixis, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
EXEL 39.14 +0.13(0.33%)
Will EXEL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EXEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EXEL
Here's Why Exelixis (EXEL) is a Strong Momentum Stock
Do Options Traders Know Something About Exelixis Stock We Don't?
EXEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Alkermes (ALKS) Up 4.7% Since Last Earnings Report?
Why Is Exelixis (EXEL) Up 3.8% Since Last Earnings Report?
Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?
Other News for EXEL
Exelixis price target raised by $4 at Morgan Stanley, here's why
Exelixis initiated with a Buy at Goldman Sachs
Exelixis initiated with bullish view at Goldman Sachs, here's why
Technical picture remains unchanged for EXEL after it falls 0.36% on September 15
Exelixis assumed with an Equal Weight at Barclays